Cargando…
Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence
BACKGROUND: Injectable bulking treatment for fecal incontinence (FI) is intended to expand tissue in the anal canal and prevent fecal leakage. Use of injectable bulking agents is increasing because it can be performed in an outpatient setting and with low risk for morbidity. This study evaluated the...
Autores principales: | Mellgren, A, Matzel, K E, Pollack, J, Hull, T, Bernstein, M, Graf, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371654/ https://www.ncbi.nlm.nih.gov/pubmed/24837493 http://dx.doi.org/10.1111/nmo.12360 |
Ejemplares similares
-
Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence
por: Sanchez, Jaime E, et al.
Publicado: (2015) -
A short- and long-term follow-up study of intersphincteric NASHA Dx implants for fecal incontinence
por: Ezra, E., et al.
Publicado: (2022) -
Identifying factors associated with clinical success in patients treated with NASHA(®)/Dx injection for fecal incontinence
por: Franklin, Howard, et al.
Publicado: (2016) -
An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence
por: Dodi, Giuseppe, et al.
Publicado: (2010) -
Safety and Efficacy of Permacol Injection in the Treatment of Fecal Incontinence
por: Al-Abed, Yahya A, et al.
Publicado: (2016)